bpc 157 ind fda status BPC-157 Approval 2026: Clinical Trials We still cannot use exosomes
Description
Biofunctionalization of nanoceria with sperminated hyaluronan enhances drug delivery performance for corneal alkali burn therapy
It is not approved for human or veterinary use or consumption
User 22 in our observational data highlighted this uncertainty when questioning if he really wanted to continue dosing twice daily in light of the 30-minute half-life
A small, 7-day clinical trial, published in 2002 offered very little information other than the reporting of no significant adverse effects. Results from a clinical safety and pharmacokinetics study on BPC-157 registered with clinicaltrials.gov in 2015 have not yet been released (study status reported as unknown)
